Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparison of rabies vaccine regimens in healthy participants
ChiCTR2400093513Phase 3Not yet recruiting
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of Rabies Vaccine (Serum-free Vero Cell) in rabies (4 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoints: Serum RVNA positive conversion rate and Geometric mean concentration. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
Rabies Vaccine (Serum-free Vero Cell)
03
Conditions
rabies
Beyond the preview
Go deeper on ChiCTR2400093513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093513.